Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2022 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Nov 16, 2022
Slide 1: Supplementary Slides Q3 2022
SUPPLEMENTARY SLIDES Q3 2022 For the period ended October 8, 2022 (Revised 11am November 16, 2022 to reflect correct basket size trend) 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q3 2022 (In CAD millions unless otherwise noted) Q3 2022 Q3 2021 % Change (1) Consolidated Revenue $17,388 $16,050 ↑ +8.3% Adjusted EBITDA $1,846 $1,674 ↑ +10.3% Adjusted EBITDA Margin 10.6% 10.4% ↑ +20 bps Adjusted Net Earnings Avaliable to Common Shareholders $
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q3 2022 (In CAD millions unless otherwise noted) Q3 2022 Q3 2021 % Change (1) Total Retail Revenue $17,130 $15,831 ↑ 8.2% Retail Revenue - Food $12,221 $11,382 ↑ 7.4% Retail Revenue - Drug $4,909 $4,449 ↑ 10.3% Pharmacy $2,466 $2,226 ↑ 10.8% Front Store $2,443
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q3 2022 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +6.9% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ≈ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +7.7